Press Releases

DiviTum®TKa approaching FDA approval

SEK 000s Q1 21/22 Q1 20/21 May-April 20/21 Net sales 381 340 2,077 Operating profit (loss) -12,238 -8,665 -40,181 Profit (loss) for the period -12,225 -8,374 -39,482 Earnings per share, after dilution -0.43 -0.36 -1.39 Significant events during the first quarter The PROMIX breast cancer study at Karolinska University Hospital has been published in the […]

August 31, 2021

CEO’s presentation ahead of the 2021 Annual General Meeting has been published

Biovica, active in cancer diagnostics, today announced that a pre-recorded presentation with CEO Anders Rylander has been published.

August 27, 2021

Biovica strengthens management team

Biovica, active in cancer diagnostics, today announced that Warren Cresswell has been appointed President Americas and will be part of the management team.

August 10, 2021

Notice of annual general meeting in Biovica International AB

The shareholders of Biovica International AB, reg. no. 556774-6150, (the “Company”) are hereby invited to the annual general meeting on Tuesday 31 August 2021.

July 30, 2021

Biovica International AB – Annual report for the financial year 2020/2021 published

Annual report for the financial year 2020/2021 for Biovica International AB is published today on our website

June 30, 2021

Biovica Year-end Report February-April 2020/2021

Preparations for the launch of DiviTum®TKa

June 17, 2021

Biovica Capital Markets Day invitation June 9

Biovica, active in cancer diagnostics, will host a virtual Capital Markets Day on Wednesday 9 June from 14.00 to 16.30.

May 22, 2021

Biovica’s DiviTumTKa shows strong capabilities in malignant melanoma

May 20, 2021 – Biovica, active in cancer diagnostics, today announces that DiviTumTKa shows prognostic and predictive capabilities in metastatic cutaneous melanoma patients undergoing immunotherapy. These results from a new study at Karolinska University Hospital will be presented at the upcoming ASCO annual meeting, June 4-8, 2021.

May 20, 2021

Biovica strengthens the management team

Biovica, active in cancer diagnostics, today announced that the company has strengthened the management team with Helle Fisker as new commercial manager and Joakim Arwidson as new quality and regulatory manager.

April 29, 2021

DiviTum®TKa budget impact model results show potential for savings in cost of care

Biovica, active in cancer diagnostics, today announced that the results from a budget impact model of monitoring with DiviTum®TKa can give savings of up to three times the extra spend relative to current management. The results will be presented at the leading health economics and outcomes research conference, ISPOR 2021 in May.

April 23, 2021